Georg Lattner

Title: Georg Lattner: Innovator in C1-Esterase Inhibitor Preparation

Introduction

Georg Lattner is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biochemistry, particularly in the development of pharmaceutical preparations. His work focuses on enhancing the stability and efficacy of C1-esterase inhibitors.

Latest Patents

Georg Lattner holds a patent for a stable C1-esterase inhibitor preparation. This invention relates to a liquid or lyophilized C1-esterase inhibitor (C1-Inh) preparation characterized by a histidine content of 5-400 mM, while notably excluding citrate or phosphate. The patent also includes a kit that features the C1-Inh preparation, showcasing its practical applications in medical treatments.

Career Highlights

Lattner is associated with Octapharma AG, a company renowned for its focus on human proteins and innovative therapies. His work at Octapharma AG has allowed him to contribute to advancements in the treatment of various medical conditions through the development of effective pharmaceutical products.

Collaborations

Georg Lattner has collaborated with notable colleagues, including Klaus Tschetschkowitsch and Almira Dugic. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of biochemistry.

Conclusion

Georg Lattner's contributions to the development of C1-esterase inhibitor preparations highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to impact medical treatments and improve patient outcomes.